Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지

In-Hospital Outcomes of Acute Renal Failure Requiring Continuous Renal Replacement Therapy in Patients with On-pump CABG

심폐기 가동하 관상동맥우회술 후 발생한 급성신부전 환자들에 있어 지속적 신대체요법의 병원 내 결과

  • Kim, Young-Du (Department of Thoracic and Cardiovascular Surgery, College of Medicine Kangnam St. Mary's Hospital, The Catholic University of Korea) ;
  • Park, Kuhn (Department of Thoracic and Cardiovascular Surgery, College of Medicine Deajeon St. Mary's Hospital, The Catholic University of Korea) ;
  • Kang, Chul-Ung (Department of Thoracic and Cardiovascular Surgery, College of Medicine Kangnam St. Mary's Hospital, The Catholic University of Korea) ;
  • Yoon, Jeong-Seob (Department of Thoracic and Cardiovascular Surgery, College of Medicine Kangnam St. Mary's Hospital, The Catholic University of Korea) ;
  • Moon, Seok-Whan (Department of Thoracic and Cardiovascular Surgery, College of Medicine Kangnam St. Mary's Hospital, The Catholic University of Korea) ;
  • Wang, Young-Pil (Department of Thoracic and Cardiovascular Surgery, College of Medicine Kangnam St. Mary's Hospital, The Catholic University of Korea) ;
  • Jo, Kuhn-Hyun (Department of Thoracic and Cardiovascular Surgery, College of Medicine Kangnam St. Mary's Hospital, The Catholic University of Korea)
  • 김영두 (가톨릭대학교 의과대학 강남성모병원 흉부외과) ;
  • 박건 (가톨릭대학교 의과대학 대전성모병원 흉부외과) ;
  • 강철웅 (가톨릭대학교 의과대학 강남성모병원 흉부외과) ;
  • 윤정섭 (가톨릭대학교 의과대학 강남성모병원 흉부외과) ;
  • 문석환 (가톨릭대학교 의과대학 강남성모병원 흉부외과) ;
  • 왕영필 (가톨릭대학교 의과대학 강남성모병원 흉부외과) ;
  • 조건현 (가톨릭대학교 의과대학 강남성모병원 흉부외과)
  • Published : 2007.01.05
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Although acute renal failure (ARF) after coronary artery bypass graft (CABG) is relatively rare, but devastating complication with high mortality. Our study aims to evaluate the effectiveness of early application of CRRT in patients with ARF which developed after on-pump CABG. Material and Method: Two hundred and eighty seven patients underwent isolated on-pump CABG between May 2002 and Feb. 2006 at our institution, of whom 15 (5.2%) needed CRRT (11 patients for postoperatively developed ARF and the remaining 4 patients with preexisting dialysis-dependent chronic renal failure (CRF) for postoperative hemodynamic and metabolic control). Criteria for early application of CRRT were as follows; decreased urine output less than 0.5cc/h/kg for 2 consecutive hours and elevated serum creatinine level greater than 2.0 mg/dL. Result: The incidence of ARF requiring CRRT after on-pump CABG was 3.9% (11/283) and the overall hospital mortality of patient with CRRT was 33.3% (5/15). Of 5 deaths, 4 were patients with postoperatively developed ARF, and 1 was a patient with pre-existing dialysis-dependent CRF patient. The mean time between the operation and the initiation of CRRT was $25.8{\pm}5.8$ hours and the mean duration of CRRT was $62.1{\pm}41.2$ hours. Of the 7 survivors who were not on dialysis-dependent preoperatively, 6 patients fully recovered renal function during hospital stay and 1 patient required permanent renal supportive treatment after discharge from hospital. Conclusion: Early application of CRRT could maintain stable postoperative hemodynamic status and make outcomes better than those of previous reports in patients with ARF which developed after on-pump CABG.

배경: 관상동맥우회술 후 발생하는 급성신부전은 비교적 드물게 발생하지만, 일단 발생하면 높은 사망률을 가지는 심각한 합병증이다. 본 연구의 목적은 심폐기를 사용한 관상동맥우회술 후 발생한 급성신부전 환자에서 지속적 신대체요법의 조기 적용의 이점 및 효과를 알아보고자 함이다. 대상 및 방법: 2002년 5월부터 2006년 2월까지 본 병원에서 심폐기 가동하에 관상동맥우회술만을 단독으로 시행 받았던 287명의 환자 중 수술 후 급성신부전이 발생하여 지속적 신대체요법을 적용한 11명과, 수술 전에 투석의존성 만성신부전이 있어 수술 후 혈역동학적 안정을 위해 지속적 신대체요법을 적용한 4명을 포함, 총 15명(15/287, 5.2%)을 대상으로 하였다. 신대체요법이 필요한 급성신부전의 진단은 심폐기 가동을 종료한 후, 이뇨를 촉진하기 위한 모든 약제의 사용 및 혈역동학적 동태의 조절에도 불구하고, 소변량의 감소(체중 및 시간당 0.5cc 미만)가 2시간 이상 지속되거나, 심장중환자실로 이송된 후에 측정한 혈중 크레아티닌(creatinine) 수치가 2.0 mg/dL 이상인 경우로 정하였다. 결과: 수술전 투석의존성 만성신부전이 있었던 4명을 제외한 283명 중 수술 후 발생한 급성신부전으로 지속적 신대체요법을 적용하였던 경우는 11명으로, 관상동맥우회술 후 급성신부전의 발생률은 3.9% (11/283)였고, 이중 4명이 병원 내에서 사망하여 원내 사망률은 36.4%였다. 수술 전 투석의존성 만성신부전이 있었던 4명은 수술 후 모두 지속적 신대체요법을 적용하였고, 이중에서는 1명이 사망하여, 지속적 신대체요법을 적용한 15명의 원내 사망률은 33.3% (5/15)였다. 수술 후 지속적 신대체요법의 적용까지 소요된 시간은 평균 $25.8{\pm}5.8$시간이었고, 평균 적용기간은 $62.1{\pm}41.2$시간이었다. 수술 후 발생한 급성신부전으로 지속적 신대체요법 적용 후 생존한 7명 중 6명은 병원에서 신기능을 회복하였고, 1명은 퇴원 후에도 영구적인 투석치료가 필요하였다. 결론: 심폐기 가동하 관상동맥우회술 후 발생한 급성신부전 환자에서 지속적 신대체요법의 조기적용으로 혈역동학적 동태의 안정적 유지와 함께 기존의 보고들에 비해 향상된 생존율을 기대할 수 있었다.

Keywords

References

  1. Mangano CM, Diamondstone LS, Ranisay JG, et al. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. Ann Intern Med 1998;128:194-203 https://doi.org/10.7326/0003-4819-128-3-199802010-00005
  2. Zanardo G, Michielon P, Paccagnella A, et al. Acute renal failure in the patient undergoing cardiac operation; prevalence, mortality rate, and main risk factors. J Thorac Cardiovasc Surg 1994;107:1489-95
  3. Chertow GM, Lazarus JM, Christianses CL, et al. Preoperative renal risk stratification. Circulation 1997;95:878-84 https://doi.org/10.1161/01.CIR.95.4.878
  4. Kellum JA, Mehta RL, Angus DC, Palevsky P, Ronco C, for the ADQI Workgroup. The first international consensus conference on continuous renal replacement therapy. Kidney Int 2002;62:1855-63 https://doi.org/10.1046/j.1523-1755.2002.00613.x
  5. Bent P, Tan HK, Bellomo R, et al. Early and intensive continuous hemofiltration for severe renal failure after cardiac surgery. Ann Thorac Surg 2001;71:832-7 https://doi.org/10.1016/S0003-4975(00)02177-9
  6. Utley JR. Cardiopulmonary bypass surgery. Curr Opin Cardiol 1992;7:267-75 https://doi.org/10.1097/00001573-199204000-00012
  7. Kang YS, Lee SY, Han SY, et al. The Clinical characteristics of patients treated with continuous renal replacement therapy. Korean J Nephrol 2002;21:93-101
  8. Baudouin SV, Wiggins J, Keough BF, Morgan CJ, Evans TW. Continuous veno-venous hemofiltration following cardiopulmonary bypass. Intensive Care Med 1993;19:290-3 https://doi.org/10.1007/BF01690550
  9. Elahi MM, Lim MY, Joseph RN, Dhannapuneni RR, Spyt TJ. Early hemofiltration improves survival in post-cardiotomy patients with acute renal failure. Eur J Cardiothorac Surg 2004;26:1027-316 https://doi.org/10.1016/j.ejcts.2004.07.039
  10. Demirkilic U, Kuralay E, Yenicesu M, et al. Timing of replacement therapy for acute renal failure after cardiac surgery. J Card Surg 2004;19:17-20 https://doi.org/10.1111/j.0886-0440.2004.04004.x
  11. Zakeri R, Freemantle N, Barnett V, et al. Relation between mild renal dysfunction and outcomes after coronary artery bypass grafting. Circulation 2005;112(suppl I):270-5 https://doi.org/10.1161/CIRCULATIONAHA.104.508937
  12. Alarabi A, Nystrom SO, Wikstrom B. Acute renal failure and outcome of continuous arteriovenous hemodialysis and continuous hemofiltration in elderly patients following cardiovascular surgery. Geriatr Neprhol Urol 1997;7:45-9 https://doi.org/10.1023/A:1008224522969
  13. Tsang GMK, Kahn I, Dar M, Clayton D, Waller D, Patel RL. Hemofiltration in a cardiac intensive care unit: time for a rational approach. ASAIO J 1996;42:M710-3 https://doi.org/10.1097/00002480-199609000-00079
  14. Ronco C, Bellomo R, Homel P, et al. Effects of different doses in continuous veno-venous hemofiltration on outcomes of acute renal failure: a prospective randomized trial. Lancet 2000;355:26-30
  15. Ascione R, Lloyd CT, Underwood MJ, Gomes WJ, Angelini GD. On-pump versus off-pump coronary revascularization: evaluation of renal function. Ann Thorac Surg 1999;68:493-8 https://doi.org/10.1016/S0003-4975(99)00566-4
  16. Bucerius J, Gummert JF, Walther T, et al. On-pump versus off-pump coronary artery bypass grafting: impact on postoperative renal failure requiring renal replacement therapy. Ann Thorac Surg 2004;77:1250-6 https://doi.org/10.1016/S0003-4975(03)01346-8